Cheng Sohanya Roshan

Cheng Sohanya Roshan is listed in filings as EVP & Chief Commercial Officer at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through May 15, 2026, including sale activity. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI) and Carisma Therapeutics, Inc. (CARM). The current snapshot covers public activity from Sep 5, 2024 to May 15, 2026. Reported amounts are shown as $3.1K to $2.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.